431 filings
Page 20 of 22
ARS
rmo 6ka9lva
30 Apr 14
Annual report to shareholders
12:00am
DEF 14A
qc31zn8y7ixpxhs4w2t7
29 Apr 14
Definitive proxy
12:00am
10-K
callv
20 Mar 14
Annual report
12:00am
8-K
fz1x1
10 Mar 14
Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014
12:00am
8-K
uoyvlao
7 Mar 14
Other Events
12:00am
S-8
5nek3ab tw4uxy7
28 Feb 14
Registration of securities for employees
12:00am
8-K
e6dcxpmk
20 Feb 14
Other Events
12:00am
8-K
xn64qi7hpru7slgl9
24 Dec 13
Other Events
12:00am
8-K
s8663c ynbrw
18 Dec 13
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study
12:00am
8-K
hc5 1zahn1j
10 Dec 13
Onconova Announces Presentation of Positive Data from Clinical Trials of Rigosertib in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting
12:00am
8-K
ex7jid g8h3z
12 Nov 13
Onconova Therapeutics, Inc. Reports Third Quarter 2013 Financial and Operational Results
12:00am
S-8
m8tgygsxtosghlkchz
13 Sep 13
Registration of securities for employees
12:00am
10-Q
uvmj6qb pz7ej52z
6 Sep 13
Quarterly report
12:00am
8-K
jdddhynb88ts t4jqs
6 Sep 13
Onconova Therapeutics, Inc. Reports Second Quarter 2013 Financial and Operational Results
12:00am
8-K
uswfu1 kg
30 Jul 13
Onconova Appoints Dr. Jerome Groopman and Anne VanLent to Board of Directors
12:00am
CT ORDER
d2i8fw6a
29 Jul 13
Confidential treatment order
12:00am
424B4
9nnvikv
25 Jul 13
Prospectus supplement with pricing info
12:00am
S-1MEF
zc3uwk
24 Jul 13
Registration of additional securities for an S-1
12:00am
EFFECT
o517 2ep2eil9bntd
24 Jul 13
Notice of effectiveness
12:00am